Abstract The current antifilarial treatments are not up to the mark partly due to deep location of filarial parasites in the human lymphatic system. We report here on the improvement in the antifilarial activity of ivermectin (IVM) using chitosan–alginate nanoparticles prepared by modified complex coacervation method. The nanoparticles were spherical having 155 nm size and 4.56 and 75.67 % loading and entrapment efficiency respectively for IVM. The delivery system maintained the sustained release and significantly augmented the microfilaricidal (MIF) activity at a single low dose (200 μg/kg body weight, subcutaneously) in contrast to much higher dose of free ivermectin (400 μg/kg body weight, subcutaneously) against human lymphatic filariid, Brugia malayi in rodent host, Mastomys coucha. To substantiate increase in MIF activity, pharmacokinetics study was designed on Wistar rats which revealed a greater peak plasma concentration (45.3 ± 1.79 ng/ml), area under the concentration curve (298 ± 38.7 ng d/ml) and extended mean residence time (23.4 ± 8.56 days)of IVM in chitosan–alginate nanoparticles. Administration of 25 mg/kg of diethylcarbamazine following nanoparticle therapy significantly improved the MIF and macrofilaricidal action of encapsulated drug and was considered superior in this study.
MIF                 0.9999719569287605^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Macrophage_migration_inhibitory_factor

nm                            0.9999999997392024^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Nanometre             

ivermectin                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Ivermectin            

IVM                           0.9999873040188638^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/In_vitro_maturation   

rodent                        0.9917237839472288^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Rodent                

Wistar rats                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Laboratory_rat        

lymphatic system              0.9999999989663593^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Lymphatic_system      

plasma                        0.9999999999754436^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Blood_plasma          

subcutaneously                0.9999992410581096^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Subcutaneous_tissue   

subcutaneously                0.9999992410581096^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Subcutaneous_tissue   

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

entrapment                    0.9999990469430026^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Entrapment            

IVM                           0.9999873040188638^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/In_vitro_maturation   

μg                            0.9999986602046982^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Microgram             

pharmacokinetics              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Pharmacokinetics      

MIF                           0.9999719569287605^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Macrophage_migration_inhibitory_factor

filarial                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Filariasis            

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

residence time                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Residence_time        

sustained release             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Time_release_technology

nanoparticle                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

Mastomys                      0.9999999999997726^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mastomys              

IVM                           0.9999873040188638^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/In_vitro_maturation   

μg                            0.9999986602046982^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Microgram             

diethylcarbamazine            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Diethylcarbamazine    

MIF                           0.9999719569287605^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Macrophage_migration_inhibitory_factor

Brugia malayi                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Brugia_malayi         

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

ivermectin                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Ivermectin            

parasites                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Parasitism            

